Targeted alpha therapy of mCRPC: Dosimetry estimate of (213)Bismuth-PSMA-617

PURPOSE: PSMA-617 is a small molecule targeting the prostate-specific membrane antigen (PSMA). In this work, we estimate the radiation dosimetry for this ligand labeled with the alpha-emitter (213)Bi. METHODS: Three patients with metastatic prostate cancer underwent PET scans 0.1 h, 1 h, 2 h, 3 h, 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Kratochwil, Clemens, Schmidt, Karl, Afshar-Oromieh, Ali, Bruchertseifer, Frank, Rathke, Hendrik, Morgenstern, Alfred, Haberkorn, Uwe, Giesel, Frederik L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700223/
https://www.ncbi.nlm.nih.gov/pubmed/28891033
http://dx.doi.org/10.1007/s00259-017-3817-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700223/
https://www.ncbi.nlm.nih.gov/pubmed/28891033
http://dx.doi.org/10.1007/s00259-017-3817-y

Ejemplares similares